Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Pain × Surveys and Questionnaires × Clear all

Phase

Phase NA 5 Phase 2 2 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 3 Prostatic Neoplasms 2 Fatigue 2 Breast Neoplasms 2 Xerostomia 1 Vomiting 1 Uterine Cervical Neoplasms 1 Psychological Well-Being 1 Parasomnias 1 Pancreatic Neoplasms 1 Pain 1 Oropharyngeal Neoplasms 1 Obesity 1 Neoplasms, Plasma Cell 1 Neoplasm Metastasis 1 Nausea 1 Multiple Myeloma 1 Mucositis 1 Motor Activity 1 Mesothelioma 1 Malignant Neoplasms of Female Genital Organs 1 Lung Neoplasms 1 Lung Diseases 1 Liver Neoplasms 1 Hyperinsulinism 1 Head and Neck Neoplasms 1 Esophagitis 1 Digestive System Diseases 1 Colon or Upper Rectum Adenocarcinoma 1 Brain Neoplasms 1

Interventions

Radiotherapy 8 Zoledronic Acid 7 Fentanyl 7 nabiximols 6 Morphine 6 Ibandronic Acid 6 Ketamine 5 Hydromorphone 5 Analgesia 5 Acetaminophen 5 Tapentadol 4 Oxycodone 4 Acupuncture Therapy 4 alvimopan 3 Ropivacaine 3 Prednisone 3 Lidocaine 3 cabozantinib 2 Tetrodotoxin 2 Mitoxantrone 2 Gabapentin 2 Duloxetine Hydrochloride 2 Docetaxel 2 Calcium 2 6'-fluoro-4',9'-dihydro-N,N-dimethyl-4-phenylspiro(cyclohexane-1,1'(3'H)-pyrano(3,4-b)indol)-4-amine 2 strontium chloride 1 resiniferatoxin 1 oxycodone-acetaminophen 1 oxycodone naloxone combination 1 ixabepilone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00142532 2009-01-14

Acupuncture for Post-Thoracotomy Pain

Memorial Sloan Kettering Cancer Center

Phase 3 Completed

Lung Neoplasms, Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡